[State of practice: creation and characterization of a Québec lung cancer patient cohort using clinical administrative data]
Boily G, Guédon A-C, Golo KT, Qureshi S, Lehuédé C, Strumpf E
Record ID 32018001703
French
Original Title:
État des pratiques: Création et caractérisation d’une cohorte québécoise de patients atteints d’un cancer du poumon à l’aide de données clinico-administratives
Authors' objectives:
INESSS has undertaken a project to explore the potential of clinical administrative data
as a lever for improving cancer care. This project has three components: the creation and
characterization of a Québec-wide cohort of lung cancer patients, the description of their
care trajectories in the ‘real world’ setting, and the assessment of certain innovative
therapies in Québec.
Authors' results and conclusions:
RESULTS: MOST RECENT PERIOD (2016 OR 2014-2016)
Findings for Québec as a whole
• Close to 10,000 new cases of lung cancer are diagnosed annually in Québec
(9,752 new cases in 2016).
• The median (and mean) age at diagnosis of people with lung cancer is
70.7 years.
2
• Lung cancer affects disproportionally more people living in geographic Census
data dissemination areas with an unfavourable material deprivation index than
living in dissemination areas with a favourable index.
• Among people diagnosed with lung cancer, approximately 6,500 lung cancer
deaths and 8,000 all-cause deaths occur annually.
• Québec is among the Canadian provinces and territories with the highest lung
cancer age-standardized incidence rates (ASIRs) and age-standardized mortality
rates (ASMRs).
• Median overall survival for Québec as a whole is 12.2 months, and the 5-year
survival rate is 24.1% (Kaplan-Meier method).
Findings according to sex
• The annual number of new lung cancer cases in women and men is similar.
However, the ASIR is higher in men than in women.
• More men than women die of lung cancer annually. The all-cause and lung
cancer ASMRs are also higher in men than in women.
• Median age-adjusted overall survival is 4.5 months longer in women than in men
(14.9 vs. 10.4 months).
Findings according to health and social services region
• There is significant inter-regional heterogeneity in the ASIRs and ASMRs.
• Overall survival in most of the regions is not different from that for Québec as a
whole.
TRENDS OVER TIME: Findings for Québec as a whole
• The lung cancer ASIR in Québec remained stable between 2002-2004 and 2014-
2016.
• Fewer and fewer people with lung cancer have been dying from the disease, but
other causes of death seem to have limited the overall decline in mortality for
these individuals (the lung cancer ASMR decreased, but the all-cause ASMR
remained stable between 2006-2007 and 2014-2016).
• Median overall survival for people with lung cancer increased by approximately
50% between 2002-2004 and 2014-2016.
Findings according to sex
• Between 2002-2004 and 2014-2016, the lung cancer ASIR increased in women
and decreased in men.
• Among men, the lung cancer ASMR and all-cause ASMR have gradually declined
over the years.
3
• Among women, the lung cancer ASMR was relatively stable between 2006-2007
and 2014-2016, with the all-cause ASMR increasing slightly during this time.
• Overall survival increased over time in both sexes, but the increase in women is
greater than in men.
Findings according to health and social services region
• The ASIR was stable in most regions of Québec between 2002-2004 and
2014-2016.
• The lung cancer ASMR has decreased over time in about one-third of the regions
of Québec.
• Between 2002-2004 and 2014-2016, overall survival increased in most regions of
Québec.
Authors' methods:
The present report addresses the first component. Since the Québec Cancer Registry
(QCR) is not yet operational, a lung cancer patient cohort was created using clinical
administrative databases (CADs). A pool of cohort candidates was first extracted from
databases for hospitalization (MED-ECHO – Maintenance et exploitation des données
pour l’étude de la clientèle hospitalière), mortality (RED-D – Registre des événements
démographiques – Fichier des décès), and physician fee-for-service billing (SMOD –
Services rémunérés à l’acte). Candidates were then subjected to a selection algorithm
consisting of two exclusion steps and five inclusion steps. The final cohort derived from
this algorithm includes a total of 133,468 incident lung cancer cases and covers the
period from 2001-2002 to 2016-2017.
There are certain limitations to creating a cancer case cohort using CADs, such as the
fact that cancer cases have to be inferred rather than directly identified as they would be
in a cancer case registry. Although there is no benchmark reference for definitively ruling
on the validity of this cohort, validation tests were performed. The results were consistent
with those expected for a valid cohort
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/creation-et-caracterisation-dune-cohorte-quebecoise-de-patients-atteints-dun-cancer-du-poumon-a-laide-de-donnees-clinico-administratives-1.html
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
Canada
Province:
Quebec
MeSH Terms
- Lung Neoplasms
- Medical Record Linkage
- Data Collection
- Registries
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
Gouvernement du Québec
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.